CABA
Income statement / Annual
Last year (2023), Cabaletta Bio, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Cabaletta Bio, Inc.'s net income was -$67.68 M.
See Cabaletta Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.43 M |
$3.68 M |
$733,000.00 |
$354,000.00 |
$104,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$1.43 M |
-$3.68 M |
-$733,000.00 |
-$354,000.00 |
-$104,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$55.42 M
|
$39.30 M
|
$32.49 M
|
$21.38 M
|
$11.67 M
|
$4.47 M
|
$0.00
|
| General & Administrative
Expenses |
$19.24 M
|
$14.84 M
|
$13.82 M
|
$12.46 M
|
$7.01 M
|
$1.73 M
|
$333,333.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$83,333.00
|
| Selling, General &
Administrative Expenses |
$19.24 M
|
$14.84 M
|
$13.82 M
|
$12.46 M
|
$7.01 M
|
$1.73 M
|
$250,000.00
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
-$6.24 M |
$0.00 |
| Operating Expenses |
$74.66 M |
$54.14 M |
$46.31 M |
$33.83 M |
$18.68 M |
$6.19 M |
$250,000.00 |
| Cost And Expenses |
$74.66 M |
$54.14 M |
$46.31 M |
$33.83 M |
$18.68 M |
$6.19 M |
$250,000.00 |
| Interest Income |
$6.99 M |
$1.16 M |
$24,000.00 |
$494,000.00 |
$1.74 M |
$235,000.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.43 M
|
$3.68 M
|
$733,000.00
|
$354,000.00
|
$104,000.00
|
$6.19 M
|
$333,333.00
|
| EBITDA |
-$73.23 M
|
-$52.96 M
|
-$45.58 M
|
-$33.48 M
|
-$18.68 M
|
-$6.01 M
|
$83,333.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$6.99 M
|
$1.16 M
|
$24,000.00
|
$494,000.00
|
$1.74 M
|
-$6.01 M
|
$83,333.00
|
| Income Before Tax |
-$67.68 M |
-$52.98 M |
-$46.29 M |
-$33.34 M |
-$16.94 M |
-$12.20 M |
-$250,000.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$1.16 M |
-$757,000.00 |
-$848,000.00 |
-$1.84 M |
-$235,000.00 |
-$333,333.00 |
| Net Income |
-$67.68 M |
-$51.81 M |
-$45.53 M |
-$32.49 M |
-$15.10 M |
-$12.20 M |
-$250,000.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.65 |
-1.77 |
-1.77 |
-1.4 |
-0.63 |
-0.84 |
-0.0104 |
| EPS Diluted |
-1.65 |
-1.77 |
-1.77 |
-1.4 |
-0.63 |
-0.84 |
-0.0104 |
| Weighted Average Shares
Out |
$40.95 M
|
$29.34 M
|
$25.74 M
|
$23.15 M
|
$24.03 M
|
$14.51 M
|
$24.03 M
|
| Weighted Average Shares
Out Diluted |
$40.95 M
|
$29.34 M
|
$25.74 M
|
$23.15 M
|
$24.03 M
|
$14.51 M
|
$24.03 M
|
| Link |
|
|
|
|
|
|
|
